Edward Cohn, MD
Vascular Surgery · Savannah, GANPI 1043247232
Payments from drug & device makers
What this record shows
This record is dominated by other: $14,990 of the $23,742 with a category attached, or 63.1%. Angiodynamics, Inc. accounts for 69.9% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $12,123 and has fallen 92.4% since, to $918 in 2025.
Across 213 payments — averaging $111.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$17K
- W. L. Gore & Associates, Inc.$2K
- Medtronic$2K
- Cook Medical LLC$625
- Silk Road Medical, Inc.$462
- Bard Peripheral Vascular, Inc.$320
- plus $2K from 18 others
What the payments were for
- Travel & lodging$1,2345%
- Food & beverage$7,51832%
- Other$14,99063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 76 | $16,589 |
| W. L. Gore & Associates, Inc. | 16 | $2,127 |
| Medtronic(3 entities) | 33 | $1,838 |
| Cook Medical LLC | 11 | $625 |
| Silk Road Medical, Inc. | 4 | $462 |
| Bard Peripheral Vascular, Inc. | 8 | $320 |
| Philips North America LLC | 11 | $317 |
| Mimedx Group, Inc. | 5 | $261 |
| Getinge USA Sales, LLC | 5 | $237 |
| Boston Scientific | 7 | $226 |
| Inari Medical, Inc. | 6 | $150 |
| Shockwave Medical, Inc | 4 | $115 |
| E.r. Squibb & Sons, L.L.C. | 6 | $83 |
| Organogenesis Inc. | 3 | $69 |
| Johnson & Johnson | 5 | $68 |
| GE HealthCare | 2 | $52 |
| Pfizer | 2 | $34 |
| Cardiovascular Systems Inc. | 3 | $31 |
| Artivion, Inc. | 1 | $31 |
| Inspiremd Ltd | 1 | $26 |
| Cvrx, Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| Smith+Nephew | 1 | $18 |
| Acera Surgical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$15,117
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,392
- HawkOne$901
- ENROUTE Transcarotid Neuroprotection System$617
- ENROUTE Transcarotid Stent$309
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$273
- VIABAHN VBX Balloon Expandable Endoprosthesis$236
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$177
- IN.PACT Admiral$139
- GENERAL VASCULAR INTERVENTION$132
- ENROUTE Transcarotid Stent System$131
- ENHANCE Transcarotid Peripheral Access Kit$131
- ENROUTE 0.014 Guidewire$131
- Cook Medical Zilver PTX$110
- Venclose Maven Catheter$108
- ENDURANT IIS$101
How this compares
$23,742 in reported general payments places this provider in the 85th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $31,393 |
| XareltoRivaroxaban | 26 | $16,628 |
| Cilostazol | 90 | $1,480 |
| ClopidogrelClopidogrel Bisulfate | 144 | $1,148 |
| Atorvastatin Calcium | 32 | $290 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $272 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $181 |
| Tramadol Hcl | 41 | $107 |
| Prednisone | 16 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $34 | $31,39347 claims |
| Johnson & JohnsonXarelto | $68 | $16,62826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Savannah
- Anthony AvinoSavannah$34K
- Davis MoonSavannah$27K
- Justin BrownSavannah$25K
- Christopher WallsSavannah$24K
- Joseph MondySavannah$22K
- Siddharth PatelAtlanta$303K
- Juan AyerdiColumbus$130K
- Albert RichardsonThomasville$103K
- Walaya Methodius-RayfordAtlanta$79K
- Eric MartinFort Gordon$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.